SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-22-000035
Filing Date
2022-11-08
Accepted
2022-11-08 16:35:39
Documents
77
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20220930.htm   iXBRL 10-Q 1413830
2 EX-31.1 exhibit311-q0322.htm EX-31.1 6555
3 EX-31.2 exhibit312-q0322.htm EX-31.2 6542
4 EX-32.1 exhibit321-q0322.htm EX-32.1 3381
10 rxrx-20220930_g1.jpg GRAPHIC 1148289
11 rxrx-20220930_g2.jpg GRAPHIC 155173
  Complete submission text file 0001601830-22-000035.txt   9725359

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20220930.xsd EX-101.SCH 43443
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20220930_cal.xml EX-101.CAL 73408
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20220930_def.xml EX-101.DEF 240757
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20220930_lab.xml EX-101.LAB 614061
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20220930_pre.xml EX-101.PRE 394585
71 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20220930_htm.xml XML 1126360
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 221369478
SIC: 2836 Biological Products, (No Diagnostic Substances)